Clinical Trial Update: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated lenalidomide in patients with relapsed or recurrent Adult T-cell leukemia/lymphoma. The study has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Adult T-Cell Leukemia-Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-05